Wegovy Guide
Wegovy is the brand-name formulation of semaglutide, FDA-approved for chronic weight management, cardiovascular risk reduction, and (since August 2025) noncirrhotic MASH with liver fibrosis. Developed by Novo Nordisk, it is available as a once-weekly subcutaneous injection (0.25–2.4 mg, or up to 7.2 mg Wegovy HD for weight reduction) and — added to the FDA label in December 2025 — a once-daily oral tablet (1.5–25 mg) for cardiovascular risk reduction or weight reduction in adults.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
At a Glance
| Generic Name | Semaglutide |
| Brand Names | Wegovy |
| FDA Status | FDA-approved for chronic weight management in adults with obesity or overweight with comorbidity (June 2021); cardiovascular risk reduction in adults with established CVD (March 2024); weight reduction in pediatric patients aged 12+ (Dec 2022); noncirrhotic MASH with moderate-to-advanced liver fibrosis in adults (August 2025); and — since December 2025 — an oral tablet form for cardiovascular risk reduction or weight reduction in adults, alongside the original injection[1] |
| Approval Date | June 4, 2021[1] |
How Wegovy Works
Wegovy mimics the GLP-1 hormone to signal fullness to the brain, slow stomach emptying, and reduce overall caloric intake. The injection reaches a maintenance dose of 1.7–2.4 mg weekly (up to 7.2 mg for weight reduction if more loss is needed); the oral tablet (added December 2025) reaches a 25 mg once-daily maintenance dose through its own 90-day titration — both deliver the same active ingredient, semaglutide, just via a different route and schedule.[2]
Dosing Schedule — Injection
Wegovy uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].
Dosing Schedule — Tablet (approved Dec 2025)
Side Effects
Common: nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%), abdominal pain (20%), headache, fatigue. Side effects typically peak during dose escalation and diminish within 4–8 weeks. Serious (rare): pancreatitis, gallstones, kidney injury, heart rate increase.[1][2]
This is not a complete list. Consult your healthcare provider or prescriber for full safety information. The complete adverse reaction profile is published in the current FDA prescribing information[1].
Clinical Trial Results
The STEP-1 trial showed Wegovy users lost an average of 14.9% of body weight (about 34 lbs) over 68 weeks compared to 2.4% in placebo. The SELECT cardiovascular outcomes trial (N=17,604) demonstrated a 20% reduction in major adverse cardiovascular events in obese patients with established CVD.[2][3][4]
Where to Get Wegovy
These telehealth providers offer access to semaglutide with online consultations and home delivery. Before you book a consult, our guide to getting Wegovy online walks through eligibility, the prescriber visit, and what legitimate pharmacy fulfillment looks like.
Found
Best for: medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help
Editorial score · methodology
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Editorial score · methodology
ShedRx
Best for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans
Editorial score · methodology
GobyMeds
Best for: no-membership, no-auto-renew compounded GLP-1 orders, from about $99/mo on a 3-month bundle
Editorial score · methodology
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Cost Comparison
Each provider's lowest ongoing monthly cash price for Wegovy, sorted cheapest first (no copays, membership fees or intro offers). Both compounded and brand-name prescriptions are generally FSA/HSA eligible under IRS Publication 502[7]. Prices may vary based on dose.
| Provider | From (ongoing) | |
|---|---|---|
| Amazon One Medical | $149/momedication billed separately | Visit |
| GoodRx | $149/morises with dose | Visit |
| Heally | $149/mo“starting at” price | Visit |
| Healthspan | $149/mo+ required membership | Visit |
| Hers | $149/mo+ required membership | Visit |
| Hims | $149/mo+ required membership | Visit |
| HuHealth | $149/mosee plan details | Visit |
| Imbue Health | $149/mo+ required membership | Visit |
| LifeMD | $149/mo+ required membership | Visit |
| Measured | $149/mo+ required membership | Visit |
| Médetone | $149/mo+ required membership | Visit |
| NovoCare Pharmacy | $149/morises with dose | Visit |
| Ro | $149/mo+ required membership | Visit |
| Sesame Care | $149/mosee plan details | Visit |
| ShedRx | $149/mo+ required membership | Visit |
| PreventiveMD | $198/mo“starting at” price | Visit |
| Found | $199/mostarting dose | Visit |
| Alloy | $248/mostarting dose | Visit |
| Aspire Health | $248/moper 4 weeks | Visit |
| Phoenix NP | $248/moper 4 weeks | Visit |
| SkinnyRx | $248/mo“starting at” price | Visit |
| Maximus | $250/mostarting dose | Visit |
| Healthicare | $269/mosee plan details | Visit |
| Mochi Health | $278/mo+ added fee | Visit |
| GOAL.MD | $294/mosee plan details | Visit |
| Good Girl Rx | $297/mo | Visit |
| eMed | $300/mo+ required membership | Visit |
| AgelessRx | $349/moafter intro offer | Visit |
| Rex MD | $349/mo | Visit |
| PlushCare | $399/mo+ required membership | Visit |
| WePeptideRx | $399/moper 4 weeks | Visit |
| Pallas Health | $499/moper 4 weeks | Visit |
| Tuyo Health | $499/mo+ required membership | Visit |
| NuDay Rx | $990/mo | Visit |
| Vital Edge | $990/mo | Visit |
| RxSpan MD | $1,349/mo | Visit |
| Trimrose | $1,349/mostarting dose | Visit |
| Corsica Health | $1,499/mosee plan details | Visit |
| altRX | $1,579/mo | Visit |
| DudeMeds | $1,585/mo3-month plan rate | Visit |
| HeliMeds | $1,599/moper 4 weeks | Visit |
| Effecty | $1,600/mosee plan details | Visit |
| GobyMeds | $1,695/mo | Visit |
| Tomorrow | $1,699/mo | Visit |
| OrderlyMeds | $1,839/mosee plan details | Visit |
| BiltRx | $1,849/mo+ consult fee | Visit |
| Bon Health | $1,869/mo+ added fee | Visit |
| myRocky | $1,869/mo | Visit |
| Concierge MD LA | $1,999/mo | Visit |
Wegovy Head-to-Head Comparisons
Short-form verdict pages comparing Wegovy to other GLP-1 options with trial-anchored data, FDA-label dosing, and current manufacturer pricing.
See all drug-vs-drug verdicts, or compare every weight loss medication we cover.
Pivotal Wegovy Trial Walkthroughs
Endpoint-by-endpoint breakdowns of the trials that shaped the Wegovy label, with primary-source numbers and FAQs.
Wegovy Patient Questions, Answered
Real patient questions about Wegovy pulled from named subreddits and answered with peer-reviewed trial data.
Wegovy Reference Cards
Scannable cheat sheets for dose schedules, missed-dose rules, and red-flag side effects — every number verified against the DailyMed FDA label.
Ranked PubMed Studies on Wegovy
Curated lists of the highest-impact peer-reviewed studies on Wegovy and related GLP-1 drugs. Every PMID is checked against its PubMed record.
Related Research on Wegovy
Deep-dive articles from our research desk with primary-source trial data, FDA label verification, and editorial analysis.
Frequently Asked Questions
Sources & methodology (as of November 2026)
- 1.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 2.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 4.SELECT Trial — Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (Lincoff AM et al.)— New England Journal of Medicine.PMID: 37952131.
- 5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 6.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 7.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Ozempic · Drugs and brands
- GLP-1 receptor · Mechanism
- STEP-1 · Major trials
- SELECT · Major trials
- Titration · Dosing
- Ozempic face · Side effects